Stay updated with breaking news from Present Data. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
North America region emerged as the largest market for the Inflammatory Bowel Disease Treatment market with around 51.5% share of the market revenue in 2020.
Cabaletta Bio Inc. (CABA) is priced at $1.25 after the most recent trading session. At the very opening of the session, the stock price was $1.89 and reached a high price of $2.10, prior to closing the session it reached the value of $1.90. The stock touched a low price of $1.10.Recently in News on
IMARC Group expects the market to reach a value of US$ 16.8 Billion by 2027, exhibiting a CAGR of 9.40% during 2022-2027.
Amryt to Present Data from OPTIMAL and MPOWERED Phase 3 Trials Open Label Extension of Mycapssa® (oral octreotide) at ENDO 2022 DUBLIN, Ireland, and...
17.05.2022 - New investigational data evaluating vonoprazan in erosive esophagitis (EE) Research highlights real-world evidence of unmet needs that exists for the treatment of Helicobacter pylori (H. pylori) infection Phathom research recognized with multiple ... Seite 1